TY - JOUR
T1 - Adherence to guideline‐directed medical treatments in heart failure. A scientific statement of the Heart Failure Association ( HFA ) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy
AU - Savarese, Gianluigi
AU - Lindberg, Felix
AU - Cannata, Antonio
AU - Adamo, Marianna
AU - Ambrosio, Giuseppe
AU - Ameri, Pietro
AU - Anker, Markus S.
AU - Bäck, Magnus
AU - Bayes‐Genis, Antoni
AU - Ben Gal, Tuvia
AU - Braunschweig, Frieder
AU - Chioncel, Ovidiu
AU - D'Elia, Emilia
AU - El‐Tamimi, Hassan
AU - Filippatos, Gerasimos
AU - Girerd, Nicolas
AU - Hill, Loreena
AU - Jankowska, Ewa
AU - Khunti, Kamlesh
AU - Lewis, Basil S.
AU - Moura, Brenda
AU - Amir, Offer
AU - Paolillo, Stefania
AU - Piepoli, Massimo
AU - Shehab, Abdulla
AU - Simpson, Maggie
AU - Skouri, Hadi
AU - Stolfo, Davide
AU - Tocchetti, Carlo Gabriele
AU - Vitale, Cristiana
AU - Volterrani, Maurizio
AU - von Haehling, Stephan
AU - Wassmann, Sven
AU - Yilmaz, Mehmet Birhan
AU - Kaski, Juan Carlos
AU - Dobrev, Dobromir
AU - Metra, Marco
AU - Rosano, Giuseppe M.C.
N1 - © 2025 The Author(s). European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
PY - 2025/11/9
Y1 - 2025/11/9
N2 - Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline‐directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non‐adherence represents a critical barrier limiting real‐world efficacy of GDMT. This scientific statement aims to provide a comprehensive framework for understanding, measuring, and addressing medication non‐adherence in HF management across diverse healthcare settings. Addressing medication non‐adherence requires systematic, multifaceted approaches targeting individual patient barriers while implementing system‐level interventions. Polypills, digital monitoring platforms, enhanced patient education and empowerment, and multidisciplinary care models represent promising strategies to optimize therapeutic adherence and improve clinical outcomes in HF management.
AB - Heart failure (HF) affects over 60 million individuals globally. Contemporary guideline‐directed medical therapies (GDMT) reduce cardiovascular mortality and HF hospitalizations. However, medication non‐adherence represents a critical barrier limiting real‐world efficacy of GDMT. This scientific statement aims to provide a comprehensive framework for understanding, measuring, and addressing medication non‐adherence in HF management across diverse healthcare settings. Addressing medication non‐adherence requires systematic, multifaceted approaches targeting individual patient barriers while implementing system‐level interventions. Polypills, digital monitoring platforms, enhanced patient education and empowerment, and multidisciplinary care models represent promising strategies to optimize therapeutic adherence and improve clinical outcomes in HF management.
KW - Fixed‐dose combinations
KW - Heart failure
KW - Guidelines
KW - Multidisciplinary
KW - Adherence
KW - Polypill
KW - Education
KW - Digital
UR - https://pure.ulster.ac.uk/en/publications/5b4c3a7b-1fb2-4220-94df-fc0b0a87f38f
UR - https://www.scopus.com/pages/publications/105021334591
U2 - 10.1002/ejhf.70090
DO - 10.1002/ejhf.70090
M3 - Article
SN - 1879-0844
SP - 1
EP - 16
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
ER -